However, in individuals with HER2-positive BC, the analysis of the lipoprotein profile using nuclear magnetic resonance demonstrated an enhanced level of specific VLDL subfractions, which served as a marker of plasma lipid alteration compared to control women, even with similar BMI between the groups. The gene discussed is ERBB2; the disease is breast cancer.